Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research
Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research
Immunobiology and treatment of cutaneous T-cell lymphoma
Expert Rev Clin Immunol. 2024 Mar 7:1-12. doi: 10.1080/1744666X.2024.2326035. Online ahead of print.ABSTRACTINTRODUCTION: Primary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides and its leukemic variant Sezary syndrome, as well as the CD30+ lymphoproliferative disorders.AREAS COVERED: In this review, we provide a summary of the current literature on CTCL, with a focus on the immunopathogenesis and treatment of mycosis fungoides and Sezary syndrome.EXPERT OPINION: Recent advances in immunology have provided new insights int...
Source: Expert Review of Clinical Immunology - March 7, 2024 Category: Allergy & Immunology Authors: Rishi R Goel Alain H Rook Source Type: research
Predictive and prognostic biomarkers in patients with Mycosis fungoides and S ézary syndrome (BIO-MUSE): Study protocol for a translational study
CONCLUSIONS: The study aims to investigate blood and skin with focus on immune cells and the microbiological environment to identify potential new prognostic biomarkers in MF and SS.CLINICALTRIAL: Clinicaltrials.gov NCT04904146.PMID:38436589 | DOI:10.2196/55723 (Source: Cell Research)
Source: Cell Research - March 4, 2024 Category: Cytology Authors: Emma Belfrage Sara Ek Åsa Johansson Hanna Brauner Andreas Sonesson Kristina Drott Source Type: research
Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
CONCLUSION: There appears to be a relationship between cutaneous T-cell lymphoma and the cutaneous and intestinal microbiome, as well as a possible pathophysiological pathway involved. The possible modulation of the cutaneous and intestinal microbiome or the action on the signaling inflammatory pathway, using pharmacological tools such as JAK inhibitors or IL-17 inhibitors in the latter case, could open the possibility for future therapeutic studies for cutaneous T-cell lymphoma.PMID:38435536 | PMC:PMC10904680 | DOI:10.1155/2024/9919225 (Source: Cell Research)
Source: Cell Research - March 4, 2024 Category: Cytology Authors: Daniel Rodr íguez Baeza L ía Bejarano Antonio Marta Gonz ález de Arriba Jos é Antonio Picó-Monllor Javier Ca ñueto Vicente Navarro-Lopez Source Type: research
Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
CONCLUSION: There appears to be a relationship between cutaneous T-cell lymphoma and the cutaneous and intestinal microbiome, as well as a possible pathophysiological pathway involved. The possible modulation of the cutaneous and intestinal microbiome or the action on the signaling inflammatory pathway, using pharmacological tools such as JAK inhibitors or IL-17 inhibitors in the latter case, could open the possibility for future therapeutic studies for cutaneous T-cell lymphoma.PMID:38435536 | PMC:PMC10904680 | DOI:10.1155/2024/9919225 (Source: Dermatology Research and Practice)
Source: Dermatology Research and Practice - March 4, 2024 Category: Dermatology Authors: Daniel Rodr íguez Baeza L ía Bejarano Antonio Marta Gonz ález de Arriba Jos é Antonio Picó-Monllor Javier Ca ñueto Vicente Navarro-Lopez Source Type: research
